Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K260714

MammoScreen® (5)

Therapixel

Authorized purpose: Flags calcifications, masses, asymmetries and architectural distortions on compatible FFDM or DBT screening examinations; management must not be based solely on MammoScreen output.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-06-26
FDA-cleared K253825

Saige-Dx

DeepHealth, Inc.

Authorized purpose: Concurrent detection and characterization support for screening DBT mammography

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-06-15
FDA-cleared K254131

BAC

DeepHealth, Inc.

Authorized purpose: BAC processes screening FFDM and DBT mammograms to detect the presence or absence of breast arterial calcifications at study and breast level and localize detected calcifications for qualified interpreting-physician review.

Modality
Mammography/DBT
Anatomy
Breast; breast arterial calcifications
Decision
2026-05-21
FDA-cleared K252954

MammoSightAI

Neurocareai, Inc. (Dba Savelife.Ai)

Authorized purpose: Tags screening cases as suspicious or blank to aid worklist prioritization; radiologists must review every examination and it does not mark original images.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-05-04
FDA-cleared K260320

Lunit INSIGHT MMG (v1.1.10)

Lunit, Inc.

Authorized purpose: Lunit INSIGHT MMG v1.1.10 aids physicians in detection, localization and characterization of suspicious breast-cancer areas on female screening mammograms from compatible FFDM systems, viewed after the physician's initial read as an adjunct to complete clinical interpretation.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-04-23
FDA-cleared K253077

uOmnispace.MR

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.MR provides viewing, manipulation, evaluation, and analysis of MR images, including labeled breast, brain, perfusion, vessel, cardiac, diffusion, susceptibility, dynamic, and spectroscopy workflows.

Modality
MRI
Anatomy
Whole body; brain; breast; vessels; and heart
Decision
2026-04-22
FDA-cleared K260524

uMI Panvivo (uMI Panvivo LS); uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S); uMI Panvivo (uMI Panvivo EX); uMI Panvivo (uMI Panvivo ES)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo variants acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, attenuation correction, and the labeled body-region workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Decision
2026-04-03
FDA-cleared K253796

Lunit INSIGHT DBT (V1.2)

Lunit, Inc.

Authorized purpose: Concurrent CADe/x aid for interpreting physicians to detect and characterize breast-cancer-suspicious lesions in screening DBT exams from compatible systems, marking soft-tissue lesions and calcifications with abnormality scores.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-03-26
FDA-cleared K253898

QT Scanner 2000 Model A

QT Imaging Holdings, Inc.

Authorized purpose: QT Scanner 2000 Model A uses ultrasonic reflection and transmission imaging to calculate fibroglandular tissue volume and the fibroglandular-tissue-to-total-breast-volume ratio in adult breast imaging; it is not a replacement for screening mammography.

Modality
Ultrasound
Anatomy
Adult breast
Decision
2026-03-04
FDA-cleared K253780

SIGNA™ Bolt

Ge Medical Systems, LLC

Authorized purpose: SIGNA Bolt is a whole-body MRI system for high-resolution diagnostic imaging of the labeled body regions, with supported AI-assisted reconstruction, positioning, and protocol functions.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2026-02-06
FDA-cleared K253779

SIGNA™ Sprint Select

Ge Medical Systems, LLC

Authorized purpose: SIGNA Sprint Select is a whole-body MRI system for diagnostic imaging of the labeled body regions, with supported AI-assisted reconstruction, positioning, and protocol functions.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2026-02-05
FDA-cleared K253091

ART-Plan+ (v3.1.0)

Therapanacea Sas

Authorized purpose: ART-Plan+ assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K253091. This release combined Annotate, prostate SmartPlan, and AdaptBox for supported head-and-neck, breast or thorax, and male-pelvis offline adaptive workflows, and added structures without changing the core indication.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-12-23
FDA-cleared K252482

CogNet AI-MT+

Medcognetics, Inc.

Authorized purpose: Prioritizes suspicious screening DBT examinations for MQSA interpreting physicians; every examination remains subject to full physician review.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-12-11
FDA-approved P130020/S005

Senographe Pristina 3D

GE Healthcare

PMA supplement updates digital breast tomosynthesis reconstruction with deep learning to correct sparse-view artifacts, compensate patient motion, and enhance soft-tissue lesion visibility in the synthetic 2D image.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-11-21
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251167

uDR Aurora CX

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uDR Aurora CX acquires two-dimensional X-ray images of the labeled skull, spine, chest, abdomen, extremities, limbs, and trunk for review by qualified healthcare professionals; it is not a mammography system.

Modality
X-ray/Radiography
Anatomy
Skull, spine, chest, abdomen, extremities, limbs, and trunk
Decision
2025-09-19
FDA-cleared K251399

SIGNA™ Sprint

GE Medical Systems, LLC

Authorized purpose: SIGNA Sprint is a 1.5T whole-body MRI system for diagnostic imaging of the labeled head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal regions.

Modality
MRI
Anatomy
Head; neck; temporomandibular joint; spine; breast; heart; abdomen; pelvis; joints; prostate; vessels; and musculoskeletal anatomy
Decision
2025-09-11
FDA-cleared K243685

MammoScreen BD

Therapixel

Authorized purpose: MammoScreen BD evaluates 2D mammography standard views (CC and/or MLO) from compatible FFDM and/or 2D synthetic mammography from DBT to assign an ACR BI-RADS 5th Edition breast-density category for asymptomatic women aged 40 years or older undergoing screening; it is adjunctive, not diagnostic, and patient management remains with the interpreting physician.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-08-22
FDA-cleared K251873

Saige-Dx

DeepHealth, Inc.

Authorized purpose: Saige-Dx analyzes screening DBT stacks and associated full-field digital or synthetic 2D mammograms, assigning finding and case suspicion levels to support qualified interpreting physicians; it does not replace their review or clinical judgment.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-08-11
FDA-cleared K243341

Genius AI Detection 2.0

Hologic, Inc.

Authorized purpose: Genius AI Detection 2.0 analyzes compatible digital breast tomosynthesis exams to identify and mark soft-tissue densities (masses, architectural distortions, asymmetries) and calcifications, providing lesion location/outline, confidence or Certainty of Findings, and a case score for concurrent review; the interpreting physician confirms or dismisses findings.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-07-31
FDA-cleared K251839

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo and Panvivo S acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, and the labeled oncology, cardiology, neurology, infection, inflammation, radiotherapy-planning, and interventional workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Decision
2025-07-17
FDA-cleared K250660

LUMINOS Q.namix T; LUMINOS Q.namix R

Siemens Medical Solutions

Authorized purpose: LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2025-07-14
FDA-cleared K251766

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz processes dynamic contrast-enhanced breast MRI for patients with biopsy-proven early-stage or locally advanced breast cancer, providing registration, subtraction, segmentation, 3D renderings, measurements, kinetic curves, parametric maps, MIPs, and reformats for physician visualization and analysis; results are not the sole basis for patient management.

Modality
MRI
Anatomy
Breast
Decision
2025-07-08
FDA-cleared K243679

MammoScreen® (4)

Therapixel

Authorized purpose: Identifies calcifications, masses, asymmetries and architectural distortions on compatible FFDM or DBT screening examinations; it is not a standalone diagnostic device.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-07-03
FDA-cleared K243253

6600 Ultrasound System (MyLabA50); 6600 Ultrasound System (MyLabA70)

Esaote S.p.A.

Authorized purpose: The 6600 Ultrasound System is a multifunctional diagnostic ultrasound scanner that collects, displays, and analyzes ultrasound images during ultrasound imaging procedures with supported echographic probes across the labeled cardiac, vascular, general-imaging, invasive, and women-health applications.

Modality
Ultrasound
Anatomy
Heart, vascular, abdominal, breast, musculoskeletal, small-organ, thyroid, urologic, pelvic, fetal, gynecologic, and transesophageal anatomy
Decision
2025-06-18
FDA-cleared K250886

EPIQ Series Diagnostic Ultrasound Systems; Affiniti Series Diagnostic Ultrasound Systems

Philips Ultrasound LLC

Authorized purpose: EPIQ and Affiniti are diagnostic ultrasound systems for imaging and fluid-flow analysis of the human body across the labeled abdominal, cardiac, vascular, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, small-organ, lung, and procedural applications by trained healthcare professionals.

Modality
Ultrasound
Anatomy
Abdomen, heart, cerebral and peripheral vessels, cephalic, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, breast, thyroid, testicle, lung, and procedural anatomy
Decision
2025-06-18
FDA-authorized DEN240047

Allix5

Clairity, Inc.

Authorized purpose: Allix5 generates a five-year breast-cancer-risk prediction from bilateral screening mammograms for eligible patients without known breast cancer at presentation; it is not intended to diagnose or detect cancer, recommend care, or serve as the sole determinant of care.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2025-05-30
FDA-cleared K243762

Synapse 3D Base Tools (V7.0)

FUJIFILM Corporation

Authorized purpose: Synapse 3D Base Tools assists trained professionals with reading, interpreting, reporting, and treatment planning from DICOM data from CT, MR, CR, US, NM, PT, XA, and other supported modalities; the base tools are not primary mammography interpretation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region anatomy represented in CT, MR, CR, US, NM, PT, and XA studies
Decision
2025-05-21
FDA-cleared K243793

EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System

Philips Ultrasound LLC

Authorized purpose: EPIQ and Affiniti are diagnostic ultrasound systems for imaging and fluid-flow analysis of the human body across the labeled abdominal, cardiac, vascular, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, small-organ, lung, and procedural applications, with R-Trigger supported in the cleared configuration.

Modality
Ultrasound
Anatomy
Abdomen, heart, cerebral and peripheral vessels, cephalic, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, breast, thyroid, testicle, lung, and procedural anatomy
Decision
2025-05-21
FDA-cleared K241671

6450 Ultrasound System (MyLabE80); 6450 Ultrasound System (MyLabE85)

Esaote S.p.A.

Authorized purpose: The 6450 Ultrasound System is a multifunctional diagnostic ultrasound scanner for collecting, displaying, and analyzing ultrasound images with supported probes; Virtual Navigator can display ultrasound with a second modality for additional morphology information in the labeled workflow.

Modality
Ultrasound
Anatomy
Heart, vascular, abdominal, breast, musculoskeletal, small-organ, thyroid, urologic, pelvic, fetal, gynecologic, and transesophageal anatomy
Decision
2025-05-16
FDA-cleared K251110

EPIQ Series Diagnostic Ultrasound Systems; Affiniti Series Diagnostic Ultrasound Systems

Philips Ultrasound LLC

Authorized purpose: EPIQ and Affiniti are diagnostic ultrasound systems for imaging and fluid-flow analysis of the human body across the labeled abdominal, cardiac, vascular, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, small-organ, lung, and procedural applications by trained professionals.

Modality
Ultrasound
Anatomy
Abdomen, heart, cerebral and peripheral vessels, cephalic, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, breast, thyroid, testicle, lung, and procedural anatomy
Decision
2025-05-09
FDA-cleared K243651

VersaViewer

GE Medical Systems SCS

Authorized purpose: VersaViewer supports two-dimensional, three-dimensional, and four-dimensional medical-image series processing and analysis through customizable layouts, multimodality review, and measurements for trained healthcare professionals; it is not for displaying digital mammography for diagnosis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region anatomy represented in CT, MR, PET, NM, XA, and other supported studies
Decision
2025-04-21
FDA-cleared K250177

EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System

Philips Ultrasound LLC

Authorized purpose: EPIQ and Affiniti are diagnostic ultrasound systems for imaging and fluid-flow analysis of the human body across the labeled abdominal, cardiac, vascular, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, small-organ, lung, and procedural applications, with the cleared RSM feature on supported models.

Modality
Ultrasound
Anatomy
Abdomen, heart, cerebral and peripheral vessels, cephalic, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, breast, thyroid, testicle, lung, and procedural anatomy
Decision
2025-04-10
FDA-cleared K250754

cmAngio® (V1.6)

CureMetrix, Inc.

Authorized purpose: cmAngio (V1.6) processes screening mammograms to aid a qualified interpreting physician in the manual process of identifying breast arterial calcification. It detects the presence or absence of breast arterial calcifications at the study and breast level in full-field digital mammography and digital breast tomosynthesis screening mammograms and marks BAC segments on image thumbnails for localization.

Modality
Mammography/DBT
Anatomy
Female breasts; breast arterial calcification
Decision
2025-04-10
FDA-cleared K250379

SIGNA Prime Elite

GE Medical Systems, LLC

Authorized purpose: SIGNA Prime Elite is a whole-body MR system that produces cross-sectional, spectroscopic, parametric, and dynamic images of the labeled body regions for trained physician interpretation, with contrast use depending on the region and protocol.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2025-03-17
FDA-cleared K243794

EPIQ Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System

Philips Ultrasound LLC

Authorized purpose: EPIQ and Affiniti are diagnostic ultrasound systems for imaging and fluid-flow analysis of the human body across the labeled abdominal, cardiac, vascular, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, small-organ, lung, and procedural applications in the cleared software configuration.

Modality
Ultrasound
Anatomy
Abdomen, heart, cerebral and peripheral vessels, cephalic, fetal, gynecologic, musculoskeletal, ophthalmic, urologic, breast, thyroid, testicle, lung, and procedural anatomy
Decision
2025-02-06
FDA-cleared K243688

Saige-Dx (3.1.0)

DeepHealth, Inc.

Authorized purpose: Concurrent reading aid for qualified interpreting physicians on screening DBT mammograms to identify soft-tissue lesions and calcifications that may indicate cancer and assign finding- and case-level suspicion.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-12-19
FDA-cleared K243705

Saige-Density (2.5.0)

DeepHealth, Inc

Authorized purpose: Adjunctive assignment of a BI-RADS 5th Edition breast-density category for interpreting-physician review of mammography.

Modality
Mammography/DBT
Anatomy
Breast tissue composition
Decision
2024-12-19
FDA-cleared K241831

Transpara (2.1.0)

ScreenPoint Medical B.V.

Authorized purpose: Transpara 2.1.0 is a concurrent reading aid for physicians interpreting screening full-field digital mammography and digital breast tomosynthesis, providing region and examination scores to support review of suspicious breast findings.

Modality
Mammography/DBT
Anatomy
Breast; regions suspicious for cancer on screening mammography and digital breast tomosynthesis
Decision
2024-11-25
FDA-cleared K241747

Saige-Dx

DeepHealth, Inc

Authorized purpose: Concurrent reading aid for interpreting physicians on screening DBT mammograms to detect and characterize soft-tissue lesions and calcifications that may indicate cancer.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-11-18
FDA-cleared K242130

Koios DS

Koios Medical, Inc.

Authorized purpose: Koios Decision Support (DS) is an artificial intelligence (AI)/machine learning (ML)-based computer-aided diagnosis (CADx) software device intended for use as an adjunct to diagnostic ultrasound examinations of lesions or nodules suspicious for breast or thyroid cancer. Koios DS allows the user to select or confirm regions of interest (ROIs) within an image representing a single lesion or nodule to be analyzed. The software then automatically characterizes the selected image data to generate an AI/MLderived cancer risk assessment and selects applicable lexicon-based descriptors designed to improve overall diagnostic accuracy as well as reduce interpreting physician variability. Koios DS software may also be used as an image viewer of multi-modality digital images, including ultrasound and mammography. The software includes tools that allow users to adjust, measure and document images, and output into a structured report. Koios DS software is designed to assist trained interpreting physicians in analyzing the breast ultrasound images of adult (>= 22 years) female patients with soft tissue breast lesions and/or thyroid ultrasounds of all adult (>= 22 years) patients with thyroid nodules suspicious for cancer. When utilized by an interpreting physician who has completed the prescribed training, this device provides information that may be useful in recommending appropriate clinical management.

Modality
Ultrasound
Anatomy
Breast
Decision
2024-11-15
FDA-cleared K240417

ProFound Detection (V4.0)

iCAD, Inc.

Authorized purpose: Concurrent CAD/CADx aid for interpreting physicians reading compatible DBT exams to detect soft-tissue densities and calcifications for physician confirmation or dismissal.

Modality
Mammography/DBT
Anatomy
Breast.
Decision
2024-11-08
FDA-cleared K243189

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: Visualize and analyze DCE breast MRI studies for patients with biopsy-proven early-stage or locally advanced breast cancer, including processing, measurements, and configurable finding visualization; results are not a sole basis for patient management.

Modality
MRI
Anatomy
Breast, including biopsy-proven breast tumors/findings.
Decision
2024-10-25
FDA-cleared K241490

Contour+ (MVision AI Segmentation)

MVision AI Oy

Authorized purpose: Contour+ generates initial CT and MR anatomical contours across head and neck, brain, breast, thoracoabdominal, and pelvic radiation-treatment planning workflows for qualified review and approval.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2024-10-18
FDA-cleared K242652

Lunit INSIGHT DBT v1.1

Lunit Inc.

Authorized purpose: Concurrent CADe/x aid for interpreting physicians to detect and characterize breast-cancer-suspicious lesions in screening DBT exams from compatible systems.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-10-04
FDA-cleared K241561

MammoScreen BD

Therapixel

Authorized purpose: Adjunctively assess breast tissue composition and provide an ACR BI-RADS 5th Edition breast-density category for asymptomatic women aged 40 years or older undergoing screening mammography; it is not diagnostic.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-10-02
FDA-approved P140011/S008

MAMMOMAT B.brilliant with Tomosynthesis Option

SIEMENS MEDICAL SOLUTIONS USA, INC.

The FDA PMA supplement record identifies MAMMOMAT B.brilliant with Tomosynthesis Option as digital breast tomosynthesis and approves a new PREMIA reconstruction algorithm, updated image-acquisition hardware enabling a faster tomosynthesis scan, and rebranding of the system. The FDA product-classification text states that the device generates digital three-dimensional mammographic images for breast-cancer screening and diagnosis.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-09-23
FDA-cleared K241665

Omni Legend

GE Medical Systems Israel, Functional Imaging

Omni Legend is a PET/CT system for attenuation-corrected PET with positron-emitting radiopharmaceuticals across whole-body, head, heart, brain, lung, breast, bone, gastrointestinal, lymphatic, and other organ workflows; CT can be used for diagnosis, planning, and image fusion.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2024-08-08
FDA-cleared K240301

MammoScreen® (3)

Therapixel

Authorized purpose: Concurrent reading and reporting aid for physicians interpreting screening mammograms on compatible full-field digital mammography and digital breast tomosynthesis systems, optionally using compatible prior examinations; outputs are adjunctive and must not be the sole basis for patient-management decisions.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-08-01
FDA-cleared K233108

VinDr-Mammo

VinBigData Joint Stock Company

The VinDr-Mammo is a passive notification for prioritization-only, a parallel- workflow software tool used by MQSA qualified interpreting physicians to prioritize patients with suspicious findings in the medical care environment. VinDr-Mammo utilizes an artificial intelligence algorithm to analyze 2D FFDM screening mammograms and flags those that are suggestive of the presence of at least one suspicious finding at the exam- level. VinDr-Mammo produces an exam-level output to a PACS/Workstation for flagging the suspicious case and allows worklist prioritization. MQSA qualified interpreting physicians are responsible for reviewing each exam on a display approved for use in mammography, according to the current standard of care. VinDr-Mammo device is limited to the categorization of exams, does not provide any diagnostic information beyond triage and prioritization, does not remove images from the interpreting physician’s worklist, and should not be used in lieu of full patient evaluation, or relied upon to make or confirm diagnosis. The VinDr-Mammo device is intended for use with complete 2D FFDM mammography exams acquired using validated FFDM systems only.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2024-05-23
FDA-cleared K233186

uOmnispace.MR

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.MR is a software solution for viewing, manipulating, evaluating, and analyzing medical images within healthcare institutions. The FDA indication lists MR stitching, dynamic studies, MR spectroscopy, maps and arithmetic functions, breast evaluation, brain perfusion, vessel analysis, dynamic contrast-enhanced analysis, neurological review, cardiac function, and flow analysis.

Modality
MRI
Anatomy
Breast, brain, heart, vessels, and other labeled MR anatomy
Decision
2024-04-17
FDA-cleared K233728

SIGNA Champion

GE Healthcare (Tianjin) Company Limited

Authorized purpose: The SIGNA Champion is a whole-body magnetic resonance scanner indicated to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, spectra, and dynamic images of structures or functions of the body for trained-physician interpretation that may assist diagnosis. Contrast agents may be used depending on the region.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body
Decision
2024-01-19
FDA-cleared K232808

Butterfly iQ3 Ultrasound System

Butterfly Network, Inc.

Butterfly iQ3 is a general-purpose portable ultrasound system for adult and pediatric imaging, peripheral vessels, small organs, breast, thyroid, scrotum, cardiac, abdominal, lung, urologic, and procedural-guidance workflows.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2024-01-04
FDA-cleared K231130

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz analyzes dynamic contrast-enhanced breast MRI for visualization and analysis of biopsy-proven early-stage or locally advanced breast cancer, including registration, subtraction, measurements, and three-dimensional views to support physician review.

Modality
MRI
Anatomy
Breast; early-stage or locally advanced breast cancer
Decision
2023-12-26
FDA-cleared K232096

Transpara Density 1.0.0

Screenpoint Medical B.V.

Authorized purpose: Automatically determine volumetric breast density, breast volume, and an ACR BI-RADS 5th Edition breast-density category from compatible digital mammography and digital breast tomosynthesis data to aid healthcare professionals in assessing breast tissue composition; it is not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2023-12-11
FDA-cleared K232381

LOGIQ Totus

GE Medical Systems Ultrasound and Primary care Diagnostics

Authorized purpose: LOGIQ Totus is a general-purpose diagnostic ultrasound system for trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, and transvaginal applications.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, renal, gynecologic/pelvic, pediatric, breast, testes, thyroid, neonatal and adult cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, and transvaginal anatomy
Decision
2023-12-07
FDA-cleared K231989

LOGIQ E10s, LOGIQ Fortis

GE Medical Systems Ultrasound and Primary Care Diagnostic

Authorized purpose: LOGIQ E10s and LOGIQ Fortis are general-purpose diagnostic ultrasound systems for trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications in hospitals or medical clinics.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, gynecologic/pelvic, pediatric, breast, testes, thyroid, cephalic, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative anatomy
Decision
2023-11-07
FDA-cleared K231470

Lunit INSIGHT DBT

Lunit Inc.

Authorized purpose: Concurrent CADe/x aid for interpreting physicians to detect and characterize suspected breast-cancer lesions in screening DBT exams from compatible systems.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2023-11-06
FDA-cleared K232367

cmAngio® V1.0

CureMetrix, Inc.

Authorized purpose: cmAngio processes screening FFDM and DBT mammograms to detect presence or absence of breast arterial calcifications at study and breast level and mark segments for qualified interpreting-physician review; it is not primary breast-cancer interpretation or a standalone diagnostic or treatment decision tool.

Modality
Mammography/DBT
Anatomy
Breast; breast arterial calcifications
Decision
2023-10-05
FDA-cleared K230039

uOmnispace

Shanghai United Imaging Healthcare Co., Ltd

Authorized purpose: uOmnispace is software for viewing, manipulating, communicating, storing, processing, and filming multimodality DICOM images, usable stand-alone or with cleared software options and multi-vendor applications meeting interface requirements; it is not intended to display digital mammography images for diagnosis in the United States.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region medical images, excluding U.S. digital mammography diagnosis
Decision
2023-07-20
FDA-cleared K223426

ECHELON Synergy MRI system

FUJIFILM Healthcare Corporation

Authorized purpose: The ECHELON Synergy MRI system is a 1.5T MR imaging device that provides non-ionizing physiological and clinical information and produces transverse, coronal, sagittal, oblique, and curved cross-sectional images of the head, body, or extremities for trained-physician interpretation.

Modality
MRI
Anatomy
Head, spine, cardiac, breast, abdomen, pelvis, shoulder, wrist, knee, ankle, and other labeled whole-body regions
Decision
2023-07-13
FDA-cleared K230346

Voluson SWIFT; Voluson SWIFT+

GE Medical Systems Ultrasound & Primary Care Diagnostic, LLC

Authorized purpose: Voluson SWIFT and Voluson SWIFT+ are general-purpose diagnostic ultrasound systems for qualified and trained healthcare professionals to image, measure, display, and analyze the human body and fluid across the labeled fetal/obstetric, abdominal, pediatric, small-organ, cephalic, cardiac, vascular, musculoskeletal, transrectal, and transvaginal applications in a hospital or medical clinic.

Modality
Ultrasound
Anatomy
Fetal/obstetric, abdominal, renal, gynecologic/pelvic, pediatric, breast, testes, thyroid, cephalic, cardiac, vascular, musculoskeletal, transrectal, urologic, and transvaginal anatomy
Decision
2023-06-20
FDA-cleared K222728

Radiation Planning Assistant (RPA)

University of Texas, MD Anderson Cancer Center

Radiation Planning Assistant creates initial CT-based contours and photon external-beam treatment plans for head-and-neck, cervical, breast, and whole-brain radiotherapy; every result must be imported into the user's treatment-planning system for review, editing, and final dose calculation.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2023-05-17
FDA-cleared K231190

EPIQ Series Diagnostic Ultrasound System

Philips Ultrasound LLC

Authorized purpose: The K231190 EPIQ submission adds the mL26-8 linear-array transducer for high-resolution superficial imaging, including labeled musculoskeletal, ophthalmic, pediatric, peripheral-vessel, breast, thyroid, and testicular applications, within the EPIQ diagnostic ultrasound system workflow.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2023-05-12
FDA-cleared K223623

SubtleMR (2.3.x)

Subtle Medical Inc.

Authorized purpose: MRI image enhancement by reducing image noise for head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal MRI, or increasing image sharpness for head MRI.

Modality
MRI
Anatomy
Head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal regions
Decision
2023-05-11
FDA-cleared K223501

ViewFinder Software Version 1.1

Elaitra Ltd

Authorized purpose: Provides a softcopy review environment for screening and diagnostic digital breast tomosynthesis, including visualization and image-enhancement aids.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2023-04-21
FDA-cleared K222174

RadioLens v1.0

Synapsica

Authorized purpose: RadioLens v1.0 is a medical diagnostic application for displaying, processing, storing, and transferring DICOM data other than mammography, with filtering, digital manipulation, and quantitative measurements; its optional SpindleX module analyzes potential vertebral displacement in adult cervical or lumbar spine stress X-rays and calculates measurements related to spinal-ligament injury leading to subluxation.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Spine, including cervical and lumbar vertebrae; general DICOM images excluding mammography
Decision
2023-03-28
FDA-cleared K223439

SIGNA Victor

GE Healthcare (Tianjin) Company Limited

Authorized purpose: SIGNA Victor is a whole-body magnetic-resonance scanner for high-resolution imaging, high signal-to-noise ratio, and short scan times. It is indicated to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, spectra, and dynamic images of structures or functions of the entire body, including head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions. Contrast agents may be used depending on the region, and trained physicians interpret the images.

Modality
MRI
Anatomy
Entire body including head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions
Decision
2023-02-13
FDA-cleared K222275

Saige-Density

DeepHealth, Inc.

Authorized purpose: Provides an adjunctive BI-RADS 5th Edition breast-density category to aid assessment of breast tissue composition; it is not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2022-12-16
FDA-cleared K222428

Syngo Dynamics (Version VA40F)

Siemens Medical Solutions USA, Inc.

Authorized purpose: Syngo Dynamics VA40F is a multimodality, vendor-agnostic cardiology image and information system for medical-image management and processing, with post-processing functions for image manipulation and quantification supporting interpretation and analysis for disease detection, diagnosis, and patient management within a healthcare institution's network.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Anatomy represented in multimodality cardiology medical images, excluding U.S. digital mammography diagnosis
Decision
2022-11-14
FDA-cleared K220408

AVIEW RT ACS

Coreline Soft Co.,Ltd

Authorized purpose: AVIEW RT ACS is a medical image-management and processing system for radiation-treatment planning with deep-learning auto-segmentation evidence described in the exact FDA decision material; the submission compares automated organ segmentation with a predicate using Dice similarity coefficient and 95% Hausdorff distance on CT cases.

Modality
Radiotherapy Planning Imaging
Anatomy
Organs at risk across breast, head and neck, abdomen, and pelvis CT validation cases, including lung, heart, eyes, brain, mandible, kidneys, liver, femur, and bladder
Decision
2022-11-10
FDA-cleared K221449

Genius AI Detection 2.0

Hologic, Inc.

Authorized purpose: Genius AI Detection 2.0 analyzes compatible digital breast tomosynthesis images to identify and mark soft-tissue densities and calcifications with confidence scores and case scoring for concurrent physician interpretation.

Modality
Mammography/DBT
Anatomy
Breast; soft-tissue densities, architectural distortions or asymmetries, and calcifications
Decision
2022-10-06
FDA-cleared K220080

CogNet QmTRIAGE

MedCognetics, Inc.

Authorized purpose: Passive exam-level notification and prioritization of suspicious findings in screening mammograms.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2022-09-29
FDA-cleared K221347

Transpara 1.7.2

ScreenPoint Medical B.V.

Authorized purpose: Concurrent reading aid for physicians interpreting screening FFDM/DBT to identify suspicious breast regions and estimate malignancy likelihood.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2022-08-03
FDA-cleared K220589

MAGNETOM Skyra Fit

Siemens Medical Solutions USA, Inc.

Authorized purpose: MAGNETOM Skyra Fit with syngo MR XA50A is a 3T system for broad head, body, and extremity MRI; this release includes TSE motion correction and automatic breast-biopsy fiducial detection.

Modality
MRI
Anatomy
Multi-region
Decision
2022-05-13
FDA-cleared K220105

Saige-Dx

DeepHealth, Inc.

Concurrent-reading software for screening DBT mammography that highlights suspected soft-tissue lesions and calcifications for physician review.

Modality
Mammography/DBT
Anatomy
Breast; screening DBT findings and calcifications
Decision
2022-05-12
FDA-cleared K212915

MVision AI Segmentation

MVision AI

Authorized purpose: MVision AI Segmentation automatically generates initial contours from CT images for radiotherapy planning; the contours are transferred for professional visualization, review, modification, and approval, and the labeled software is not intended for lesion or tumor detection or real-time adaptive planning.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck, brain, breast, lung and abdomen, male pelvis, and female pelvis structures
Decision
2022-05-03
FDA-cleared K213307

Eclipse II with Smart Noise Cancellation

Carestream Health, Inc.

Digitally enhances adult and pediatric radiographic x-ray images; mammography is excluded.

Modality
X-ray/Radiography
Anatomy
Exact anatomy wording was withdrawn pending re-verification.
Decision
2022-01-14
FDA-cleared K210670

BU-CAD

TaiHao Medical Inc.

Authorized purpose: Assist trained interpreting physicians in analyzing breast-ultrasound images of patients with soft-tissue breast lesions suspicious for cancer who are referred for further diagnostic ultrasound examination.

Modality
Mammography/DBT
Anatomy
Breast and suspicious soft-tissue breast lesions.
Decision
2021-12-21
FDA-cleared K212616

Koios DS

Koios Medical, Inc.

Authorized purpose: Koios DS is an artificial intelligence (AI)/machine learning (ML)-based computer-aided diagnosis (CADx) software device intended for use as an adjunct to diagnostic ultrasound examinations of lesions or nodules suspicious for breast or thyroid cancer. Koios DS allows the user to select or confirm regions of interest (ROIs) within an image representing a single lesion or nodule to be analyzed. The software then automatically characterizes the selected image data to generate an AI/ML-derived cancer risk assessment and selects applicable lexicon-based descriptors designed to improve overall diagnostic accuracy as well as reduce interpreting physician variability. Koios DS may also be used as an image viewer of multi-modality digital images, including ultrasound and mammography. The software includes tools that allow users to adjust, measure and document images, and output into a structured report. Koios DS software is designed to assist trained interpreting physicians in analyzing the breast ultrasound images of adult (>= 22 years) female patients with soft tissue breast lesions and/or thyroid ultrasounds of all adult (>= 22 years) patients with thyroid nodules suspicious for cancer. When utilized by an interpreting physician who has completed the prescribed training, this device provides information that may be useful in recommending appropriate clinical management. Limitations: Patient management decisions should not be made solely on the results of the Koios DS analysis. Koios DS software is not to be used for the evaluation of normal tissue, on sites of post-surgical excision, or images with doppler, elastography, or other overlays present in them. Koios DS software is not intended for use on portable handheld devices (e.g. smartphones or tablets) or as a primary diagnostic viewer of mammography images. The software does not predict the presence of the thyroid nodule margin descriptor, extra-thyroidal extension. In the event that this condition is present, the user may select this category manually from the margin descriptor list.

Modality
Ultrasound
Anatomy
Breast
Decision
2021-12-16
FDA-cleared K211541

MammoScreen 2.0

Therapixel

Authorized purpose: Concurrent reading aid for interpreting physicians reading screening FFDM or DBT, to identify findings and assess suspicion; it is not the sole basis for management.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-11-26
FDA-cleared K211678

Lunit INSIGHT MMG

Lunit Inc.

Authorized purpose: Aid interpreting physicians in detecting, localizing, and characterizing suspicious breast-cancer areas on mammograms from compatible FFDM systems, viewed after the physician completes the initial read.

Modality
Mammography/DBT
Anatomy
Breast.
Decision
2021-11-17
FDA-cleared K203785

ClariSIGMAM

ClariPi Inc.

Authorized purpose: Calculation of percent breast density and breast-density group information (BI-RADS A+B fatty versus C+D dense) as adjunctive information for interpreting physicians assessing breast tissue composition; not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast tissue, including fibroglandular tissue and total breast area, assessed for each breast.
Decision
2021-09-10
FDA-cleared K211431

breastscape v1.0

Olea Medical

Authorized purpose: Visualization, analysis, reporting, lesion measurement, kinetic assessment, and MR-guided breast interventional planning; when interpreted by a skilled physician, information may support screening, diagnosis, and intervention planning, but patient management must not rely solely on the results.

Modality
Mammography/DBT
Anatomy
Breast lesions and breast morphological landmarks including nipple, chest, and skin borders.
Decision
2021-08-02
FDA-cleared K211279

Volpara Imaging Software

Volpara Health Technologies Limited

Authorized purpose: Provides volumetric breast density, BI-RADS fourth- or fifth-edition density categories and dose/pressure quality metrics from raw mammography or DBT data as adjunctive information for an MQSA-qualified physician's breast-composition assessment.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-07-27
FDA-cleared K210719

Change Healthcare Anatomical AI

Change Healthcare Canada Company

Authorized purpose: Analyzes CT or MR pixel data to create anatomical descriptors for export and to help identify images, series, and studies.

Modality
CT/CTA; MRI
Anatomy
Abdomen; breast (MR only); calf; chest; elbow; foot; forearm; hand; head; arm; knee; neck; pelvis; shoulder; cervical spine; thoracic spine; lumbar spine; thigh
Decision
2021-07-20
FDA-cleared K211506

PowerLook Density Assessment V4.0

iCAD, Inc.

Authorized purpose: Provide a breast-density category from synthetic 2D images generated from DBT to aid assessment of breast tissue composition; the output is adjunctive and not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-07-12
FDA-cleared K210404

Transpara 1.7.0

ScreenPoint Medical B.V.

Authorized purpose: Concurrent reading aid for physicians interpreting screening FFDM and DBT to identify suspicious regions and assess malignancy likelihood.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-06-02
FDA-cleared K203517

Saige-Q

DeepHealth, Inc.

Authorized purpose: Provides passive worklist prioritization for compatible FFDM and DBT screening mammograms.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-04-16
FDA-cleared K202441

Eclipse II with Smart Noise Cancellation

Carestream Health, Inc.

Authorized purpose: Eclipse II with Smart Noise Cancellation digitally enhances radiographic images generated by supported X-ray devices for adult and pediatric use; the cleared function is for projection radiography and excludes mammography.

Modality
X-ray/Radiography
Anatomy
Adult and pediatric radiographic anatomy excluding mammography
Decision
2021-04-02
FDA-cleared K203822

ProFound AI Software V3.0

iCAD Inc.

Authorized purpose: Concurrent or secondary CAD assistance to interpreting physicians for detection, localization, and characterization of soft-tissue densities (masses, architectural distortions, and asymmetries) and calcifications; not a primary read.

Modality
Mammography/DBT
Anatomy
Breast, including soft-tissue densities and calcifications in 3D DBT slices.
Decision
2021-03-12
FDA-cleared K203182

SubtleMR

Subtle Medical, Inc.

Authorized purpose: SubtleMR is MRI image-processing software for reducing noise in supported head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal MRI or increasing sharpness for head MRI within the labeled workflow.

Modality
MRI
Anatomy
Multi-region
Decision
2021-02-26
FDA-cleared K203103

Synapse 3D, Synapse 3D Base Tools v6.1

Fujifilm Corporation

Authorized purpose: Synapse 3D Base Tools is medical-imaging software that provides trained medical professionals tools to aid reading, interpreting, reporting, and treatment planning. It accepts DICOM images from imaging devices including CT, MR, CR, US, NM, PT, and XA, and provides viewing, volume rendering, multiplanar reconstruction, fusion, subtraction, segmentation, measurements, annotations, reporting, image management, and modality-specific CT and MR tools. It is not intended for primary diagnostic interpretation of mammography images.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient anatomy represented in supported DICOM CT, MR, CR, US, NM, PT, and XA images; mammography excluded
Decision
2021-02-09
FDA-cleared K201411

Visage Breast Density

Visage Imaging GmbH

Authorized purpose: Assesses breast density from compatible full-field digital mammography and DBT studies.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2021-01-29
FDA-approved P200003

Imagio Breast Imaging System

Seno Medical Instruments, Inc.

Imagio combines ultrasound and optoacoustic imaging to evaluate palpable or non-palpable breast abnormalities in adults referred for diagnostic workup. Ultrasound can assign BI-RADS, and optoacoustic features can assist assessment of BI-RADS 3-5 masses based on vascularity and blood oxygen saturation.

Modality
Optoacoustic Imaging
Anatomy
Breast
Decision
2021-01-11
FDA-cleared K201019

Genius AI Detection

Hologic, Inc.

Authorized purpose: Genius AI Detection analyzes compatible digital breast tomosynthesis images to identify and mark soft-tissue densities and calcifications with confidence scores and case scoring for concurrent physician interpretation.

Modality
Mammography/DBT
Anatomy
Breast; soft-tissue densities and calcifications in digital breast tomosynthesis
Decision
2020-11-18
FDA-cleared K202013

WRDensity by Whiterabbit.ai

Whiterabbit.ai Inc.

Authorized purpose: Analyzes for-presentation digital breast X-ray data to provide breast-density information.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2020-10-30
FDA-cleared K201632

TOMTEC-ARENA

TOMTEC Imaging Systems GmbH

TOMTEC-ARENA quantifies and reports cardiovascular, fetal, and abdominal structures and functions from supported clinical images and can exchange data with IMAGE-ARENA and third-party applications.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2020-08-14
FDA-cleared K200905

HealthMammo

Zebra Medical Vision Ltd.

Authorized purpose: Provides passive prioritization-only parallel workflow for suspicious findings in 2D FFDM screening mammograms.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2020-07-16
FDA-cleared K192601

uWS-MR

Shanghai United Imaging Healthcare Co., Ltd

Authorized purpose: uWS-MR provides MR image viewing, manipulation, communication, storage, stitching, fusion, spectroscopy, parameter maps, breast evaluation, brain perfusion, and related processing for interpretation and evaluation within healthcare institutions.

Modality
MRI
Anatomy
Head, body, breast, brain, and other anatomy represented in supported MR examinations
Decision
2020-06-01
FDA-cleared K192854

MammoScreen

Therapixel

Authorized purpose: MammoScreen is a concurrent reading aid for interpreting physicians reviewing screening full-field digital mammography; it marks suspicious soft-tissue lesions and calcifications and provides suspicion scores, while patient management is not based solely on the device.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2020-03-25
FDA-cleared K193229

Transpara

ScreenPoint Medical B.V.

Authorized purpose: Transpara version 1.6 is a concurrent screening aid for FFDM and DBT that presents suspicious-region marks, region scores from 0 to 100, and an exam score from 1 to 10 for physician review.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2020-03-05
FDA-cleared K192973

densitas densityai

Densitas, Inc.

Authorized purpose: Provides an ACR BI-RADS 5th Edition breast-density category from compatible full-field digital mammography and DBT as adjunctive information, not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2020-02-19
FDA-cleared K192287

Transpara

Screenpoint Medical B.V.

Authorized purpose: Transpara version 1.5 is a concurrent screening full-field digital mammography aid that presents suspicious-region marks and scores for physician review and cannot be used as the sole basis for interpretation.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2019-12-10
FDA-cleared K190442

Koios DS for Breast

Koios Medical, Inc.

Authorized purpose: Adjunctive breast-cancer decision support during diagnostic ultrasound for patients referred for further diagnostic ultrasound; classifies a user-selected lesion ROI into four BI-RADS-aligned categories and assesses shape and orientation.

Modality
Mammography/DBT
Anatomy
Soft-tissue breast lesions.
Decision
2019-07-03
FDA-cleared K183285

cmTriage

CureMetrix, Inc

Authorized purpose: Passive, prioritization-only notification of 2D FFDM screening mammograms with at least one suspicious finding at the exam level; not diagnostic.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2019-03-08
FDA-cleared K181704

Transpara

ScreenPoint Medical BV

Authorized purpose: Transpara is a concurrent reading aid for screening mammograms that marks suspicious regions, lesions, and calcifications and provides malignancy scores for qualified physician review; patient management is not based solely on the device.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2018-11-21
FDA-cleared K182310

Volpara Imaging Software

Volpara Health Technologies Limited

Authorized purpose: Volpara Imaging Software processes raw digital breast X-ray and tomosynthesis data to calculate breast-density maps, volumetric density, and a BI-RADS density category as an adjunct to qualified physician interpretation.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2018-09-21
FDA-cleared K173574

DenSeeMammo

Statlife

Authorized purpose: Adjunctive estimation of the BI-RADS 5th Edition breast-density category from processed digital 2D mammograms to aid radiologists; not diagnostic.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2018-06-26
FDA-cleared K180589

DR 800 with MUSICA Dynamic

Agfa HealthCare N.V.

Authorized purpose: DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2018-04-05
FDA-cleared K170540

DM-Density

Densitas, Inc.

DM-Density is a software application intended for use with compatible full field digital mammography systems. DMDensity calculates percent breast density defined as the ratio of fibroglandular tissue to total breast area estimates. DM-Density provides these numerical values for each breast as well as a density category to aid interpreting physicians in the assessment of breast tissue composition. DM-Density produces adjunctive information. It is not a diagnostic aid.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2018-02-23
FDA-cleared K173588

Illumeo System

Philips Medical Systems Technologies, Ltd.

Authorized purpose: Illumeo is an image-management system for trained professionals, including radiologists. It is a software package used with general-purpose computing hardware to acquire, store, distribute, process, and display images and associated data throughout a clinical environment, including digital image processing, measurement, manipulation, quantification, communication, and storage. It is not to be used for mammography.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Images and associated data represented in the clinical environment; mammography excluded
Decision
2018-01-12
FDA-cleared K173420

Radiomics App v1.0

Microsoft Corp.

Authorized purpose: Microsoft Radiomics App v1.0 is a software-only medical device for trained radiation oncologists, dosimetrists, and physicists to derive organ and tumor contours for radiation-treatment planning. It supports CT and MR images, image and contour review, contour creation and modification, transfer to treatment-planning systems, adaptive-therapy support, archiving, tumor and healthy-structure localization, image fusion, and three-dimensional rendering. Images reviewed with the software should not be used for primary image interpretations, and it is not for digital mammography.

Modality
Radiotherapy Planning Imaging
Anatomy
CT and MR images; tumors and healthy anatomical structures for radiotherapy planning
Decision
2017-12-27
FDA-cleared K163623

Quantra

HOLOGIC, INC.

Authorized purpose: Quantra 2.2 analyzes digital breast X-ray images and categorizes breast density to provide additional information for a radiologist's assessment.

Modality
Mammography/DBT
Anatomy
Breast; mammographic breast-density composition
Decision
2017-10-20
FDA-cleared K172385

Clarius Ultrasound System

Clarius Mobile Health Corp.

Authorized purpose: The Clarius Ultrasound Scanner is a software-based diagnostic ultrasound imaging system for trained healthcare professionals across labeled abdominal, thoracic, musculoskeletal, breast, thyroid, testicular, pediatric, neonatal, cardiac, vascular, transrectal, transvaginal, and procedural workflows.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2017-09-14
FDA-authorized DEN170022

QuantX

Quantitative Insights, Inc

Authorized purpose: QuantX is breast MRI software for the labeled management, analysis, visualization, and decision-support workflow; exact image inputs, outputs, and use remain submission-specific.

Modality
MRI
Anatomy
Breast
Decision
2017-07-19
FDA-approved P160009

PowerLook® Tomo Detection Software

iCAD Inc

Concurrent computer-aided detection for radiologists interpreting compatible GE Senoclaire breast tomosynthesis examinations, with detected soft-tissue densities blended into the synthetic two-dimensional mammography image.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2017-03-24
FDA-cleared K161959

ClearView cCAD

ClearView Diagnostics Inc.

ClearView cCAD is a software application designed to assist skilled physicians in analyzing breast ultrasound images. It automatically classifies shape and orientation characteristics of user-selected regions of interest. this device uses multivariate pattern recognition methods to perform characterization and classification of images.

Modality
Ultrasound
Anatomy
Breast
Decision
2016-12-28
FDA-approved P150043

QVCAD System

QView Medical, Inc.

Authorized purpose: The QVCAD System is indicated as an aid to the reader during screening procedures in searching images of female breasts produced by the somo.v Automated Breast Ultrasound System, for screening mammography BI-RADS Assessment Category 1 or 2 and BI-RADS composition or density c or d, to detect mammography-occult lesions in regions not known to have suspicious findings. The indicators are not intended for diagnostic characterization of suspicious findings.

Modality
Ultrasound
Anatomy
Female breasts; mammography-occult lesions in non-suspicious regions
Decision
2016-11-09
FDA-cleared K161625

PixelShine

ALGOMEDICA

Authorized purpose: PixelShine is intended for networking, communication, processing, and enhancement of CT images in DICOM format to assist professional radiologists and specialists in reaching their own diagnosis. Processing is not effective for lesions, masses, or abnormalities smaller than 3 mm, and the device is not intended for diagnostic interpretation of mammography images.

Modality
CT/CTA
Anatomy
CT images represented in DICOM format
Decision
2016-09-19
FDA-cleared K153427

Volpara Imaging Software

Matakina Technology LTD

Authorized purpose: Volpara processes raw data from digital breast x-ray systems, including tomosynthesis, to calculate density maps, volumetric breast density, and BI-RADS breast-density categories as adjunctive information for an MQSA-qualified interpreting physician.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2016-01-07
FDA-cleared K142037

QUANTRA

HOLOGIC, INC.

Authorized purpose: Quantra version 2.1 calculates volumetric and area breast-density measures and density categories from supported digital mammography images as an adjunct, not a diagnostic result.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2014-10-10
FDA-cleared K133259

YSIO MAX

SIEMENS MEDICAL SOLUTIONS USA, INC.

Authorized purpose: YSIO MAX is a digital radiography system for whole-body skull, chest, abdomen, and extremity imaging in pediatric, adult, and bariatric patients, including supported emergency and small-intervention positions; it is not a mammography system.

Modality
X-ray/Radiography
Anatomy
Multi-region
Decision
2014-01-24
FDA-cleared K082483

QUANTRA

HOLOGIC, INC.

Authorized purpose: Quantra version 1.1 calculates a volumetric breast-density ratio from supported Hologic full-field digital mammography images on the Cenova server as an adjunct, not a diagnostic result.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2008-09-12
FDA-approved P010034

SECOND LOOK ™

ICAD, INC.

Authorized purpose: The Second Look computer-aided detection system for mammography is intended to identify and mark regions of interest on standard mammographic views after the initial reading has been completed, bringing them to the radiologist's attention and helping minimize observational oversights by identifying areas that may warrant a second review.

Modality
Mammography/DBT
Anatomy
Breast / standard mammographic views
Decision
2002-01-31
FDA-approved P970058

M1000 IMAGECHECKER

Hologic, Inc.

Authorized purpose: The ImageChecker M1000 is a computer system intended to identify and mark regions of interest on routine screening mammograms after the initial reading has been completed, bringing them to the radiologist's attention and helping minimize observational oversights by identifying areas that may warrant a second review.

Modality
Mammography/DBT
Anatomy
Breast / routine screening mammograms
Decision
1998-06-26